Literature DB >> 9343224

Characterization of human serotype 1 astrovirus-neutralizing epitopes.

D M Bass1, U Upadhyayula.   

Abstract

Astroviruses are important agents of pediatric gastroenteritis. To better understand astrovirus antigenic structure and the basis of protective immunity, monoclonal antibodies (MAbs) were produced against serotype 1 human astrovirus. Four MAbs were generated. One MAb (8G4) was nonneutralizing but reacted to all seven serotypes of astrovirus by enzyme-linked immunosorbentassay (ELISA) and immunoperoxidase staining of infected cells. Three MAbs were found to have potent neutralizing activity against astrovirus. The first (5B7) was serotype 1 specific, another (7C2) neutralized all seven human astrovirus serotypes, while the third (3B2) neutralized serotypes 1 and 7. Immunoprecipitation of radiolabeled astrovirus proteins from supernatants of astrovirus-infected cells showed that all three neutralizing antibodies reacted with VP29. MAb 5B7 also reacted strongly with VP26. A competition ELISA showed that all three neutralizing antibodies competed with each other for binding to purified astrovirus virions, suggesting that their epitopes were topographically in close proximity. None of the neutralizing MAbs competed with nonneutralizing MAb 8G4. The neutralizing MAbs were used to select antigenic variant astroviruses, which were then studied in neutralization assays. These assays also suggested a close relationship between the respective epitopes. All three neutralizing MAbs were able to prevent attachment of radiolabeled astrovirus particles to human Caco 2 intestinal cell monolayers. Taken together, these data suggest that the astrovirus capsid protein VP29 may be important in viral neutralization, heterotypic immunity, and virus attachment to target cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343224      PMCID: PMC192330     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Growth and characterisation of human faecal astrovirus in a continuous cell line.

Authors:  M M Willcocks; M J Carter; F R Laidler; C R Madeley
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Temporal synthesis of proteins and RNAs during human astrovirus infection of cultured cells.

Authors:  S S Monroe; S E Stine; L Gorelkin; J E Herrmann; N R Blacklow; R I Glass
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  Human astrovirus serotypes.

Authors:  J B Kurtz; T W Lee
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

5.  Antigenic characterization of cell-cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies.

Authors:  J E Herrmann; R W Hudson; D M Perron-Henry; J B Kurtz; N R Blacklow
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

6.  Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses.

Authors:  S S Monroe; B Jiang; S E Stine; M Koopmans; R I Glass
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Prevalence of human astrovirus serotypes in the Oxford region 1976-92, with evidence for two new serotypes.

Authors:  T W Lee; J B Kurtz
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

8.  Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus.

Authors:  H B Greenberg; J Valdesuso; K van Wyke; K Midthun; M Walsh; V McAuliffe; R G Wyatt; A R Kalica; J Flores; Y Hoshino
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

9.  Characterization and seroepidemiology of a type 5 astrovirus associated with an outbreak of gastroenteritis in Marin County, California.

Authors:  K Midthun; H B Greenberg; J B Kurtz; G W Gary; F Y Lin; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Antigenic mapping of the surface proteins of rhesus rotavirus.

Authors:  R D Shaw; P T Vo; P A Offit; B S Coulson; H B Greenberg
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

View more
  26 in total

1.  Proteolytic processing of the astrovirus capsid.

Authors:  D M Bass; S Qiu
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein.

Authors:  Ernesto Méndez; Teresa Fernández-Luna; Susana López; Martha Méndez-Toss; Carlos F Arias
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 3.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Crystal structure of the avian astrovirus capsid spike.

Authors:  Rebecca M DuBois; Pamela Freiden; Shauna Marvin; Muralidhar Reddivari; Richard J Heath; Stephen W White; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Crystal structure of the human astrovirus capsid spike.

Authors:  Jinhui Dong; Liping Dong; Ernesto Méndez; Yizhi Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.

Authors:  Patrick R Harrington; Lisa Lindesmith; Boyd Yount; Christine L Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Characterization of human astrovirus cell entry.

Authors:  Ernesto Méndez; Claudia Muñoz-Yañez; Claudia Sánchez-San Martín; Gabriela Aguirre-Crespo; M del Rocio Baños-Lara; Michelle Gutierrez; Rafaela Espinosa; Yunuén Acevedo; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

8.  Isolation of Neutralizing Monoclonal Antibodies to Human Astrovirus and Characterization of Virus Variants That Escape Neutralization.

Authors:  Rafaela Espinosa; Tomás López; Walter A Bogdanoff; Marco A Espinoza; Susana López; Rebecca M DuBois; Carlos F Arias
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

9.  Prevalence of astroviruses in a children's hospital.

Authors:  S Shastri; A M Doane; J Gonzales; U Upadhyayula; D M Bass
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Authors:  Rheba S Bonaparte; Pamela S Hair; Deepa Banthia; Dawn M Marshall; Kenji M Cunnion; Neel K Krishna
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.